Moore Kevin D 4
4 · TransBiotec, Inc. · Filed Jan 16, 2020
Insider Transaction Report
Form 4
Moore Kevin D
DirectorChief Executive Officer
Transactions
- Award
Common Stock
2019-12-31+800,000→ 2,400,000 total - Award
Common Stock
2019-10-31+800,000→ 800,000 total - Award
Common Stock
2019-11-30+800,000→ 1,600,000 total - Award
Common Stock Option
2019-11-22+35,200,000→ 35,200,000 totalExercise: $0.01From: 2019-12-22Exp: 2029-12-22→ Common Stock (35,200,000 underlying)
Footnotes (2)
- [F1]Under the terms of the Reporting Person's Employment Agreement as the Issuer's Chief Executive Officer, he is entitled to 800,000 shares of the Issuer's common stock on each of October 31, 2019, November 30, 2019 and December 31, 2019.
- [F2]Pursuant to the Reporting Person's Employment Agreement, he was issued a stock option to acquire 35,200,000 shares of the Issuer's common stock at $0.00792 per share. The shares vest in equal monthly installments of 977,777 shares per month for 36 months and expire ten years from the vesting date.